Abstract
Purpose. The peptide transporter PEPT2 was recently shown to be functionally active in rat choroid plexus, suggesting that it may play a role in neuropeptide homeostasis in the cerebrospinal fluid. This study, therefore, examined the role of PEPT2 in mediating neuropeptide uptake into choroid plexus.
Methods. Whole-tissue rat choroid plexus uptake studies were performed on GlySar in the absence and presence of neuropeptides and on carnosine.
Results. The neuropeptides NAAG, CysGly, GlyGln, kyotorphin, and carnosine inhibited the uptake of radiolabeled GlySar at 1.0 mM concentrations. In contrast, TRH, [D-Arg2]-kyotorphin, glutathione, and homocarnosine did not inhibit GlySar uptake. Kyotorphin, an analgesic, was a competitive inhibitor of GlySar with a Ki of 8.0 μM. The direct uptake of carnosine was also shown to be mediated by PEPT2 in isolated choroid plexus (Km = 39.3 μM; Vmax = 73.9 pmol/mg/min). Radiolabeled carnosine uptake was inhibited by 1.0 mM concentrations of GlySar or carnosine but not homocarnosine, L-histidine, or β-alanine.
Conclusions. These findings indicate that PEPT2 mediates the uptake of a diverse group of neuropeptides in choroid plexus, and suggests a role for PEPT2 in the regulation of neuropeptides, peptide fragments, and peptidomimetics in cerebrospinal fluid.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
F. Döring, J. Walter, J. Will, M. Focking, M. Boll, S. Amasheh, W. Clauss, and H. Daniel. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J. Clin. Invest. 101:2761-2767 (1998).
H. Daniel and M. Herget. Cellular and molecular mechanisms of renal peptide transport. Am. J. Physiol. 273:F1-8 (1997).
H. Shen, D. E. Smith, T. Yang, Y.G. Huang, J. B. Schnermann, and F. C. Brosius III. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol. 276:F658-665 (1999).
U. V. Berger and M. A. Hediger. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat. Embryol. (Berl) 199:439-449 (1999).
A. Novotny, J. Xiang, W. Stummer, N. S. Teuscher, D. E. Smith, and R. F. Keep. Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J. Neurochem. 75:321-328 (2000).
T. Yamashita, S. Shimada, W. Guo, K. Sato, E. Kohmura, T. Hayakawa, T. Takagi, and M. Tohyama. Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 272:10205-10211 (1997).
N. S. Teuscher, A. Novotny, R. F. Keep, and D. E. Smith. Functional evidence for presence of PEPT2 in rat choroid plexus: Studies with glycylsarcosine. J. Pharmacol. Exp. Ther. 294:494-499 (2000).
J. Laterra, R. F. Keep, A. L. Betz, and G. W. Goldstein. Blood-brain-cerebrospinal fluid barriers. In G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher, and M. D. Uhler (eds.), Basic Neurochemistry: Molecular, Cellular and Medical Aspects, Lippincott-Raven Publishers, Philadelphia, 1999 pp. 671-689.
M. Segal. The blood-CSF barrier and the choroid plexus. In W. M. Pardridge (ed.) Introduction to the blood-brain barrier: Methodology, Biology, and Pathology, Cambridge University Press, Cambridge, U.K., 1998 pp. 251-258.
F. H. Leibach, and V. Ganapathy. Peptide transporters in the intestine and the kidney. Annu. Rev. Nutr. 16:99-119 (1996).
Y. Cheng, and W. H. Prusoff. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
B.V. Zlokovic, M. B. Segal, D. J. Begley, H. Davson, and L. Rakic. Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res. 358:191-199 (1985).
T. Fujita, T. Kishida, N. Okada, V. Ganapathy, F. H. Leibach, and A. Yamamoto. Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: Implication of high affinity type H+/peptide transporter PEPT2 mediated transport system. Neurosci. Lett. 271:117-120 (1999).
F. Döring, J. Will, S. Amasheh, W. Clauss, H. Ahlbrecht, and H. Daniel. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J. Biol. Chem. 273:23211-23218 (1998).
H. Yajima, H. Ogawa, H. Ueda, and H. Takagi. Studies on peptides. XCIV. Synthesis and activity of kyotorphin and its analogs. Chem. Pharm. Bull. 28:1935-1938 (1980).
L. S. Goodman, A. Gilman, J. G. Hardman, A. G. Gilman, and L. E. Limbird. Goodman & Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill Health Professions Division, New York, 1996.
K. Nishimura, K. Kaya, T. Hazato, H. Ueda, M. Satoh, and H. Takagi. Kyotorphin like substance in human cerebrospinal fluid of patients with persistent pain. Masui 40:1686-1690 (1991).
T. Arima, Y. Kitamura, T. Nishiya, T. Taniguchi, H. Takagi, and Y. Nomura. Effects of kyotorphin (L-tyrosyl-L-arginine) on [3H]NG-nitro-L-arginine binding to neuronal nitric oxide synthase in rat brain. Neurochem. Int. 30:605-611 (1997).
V. Ganapathy, and F. H. Leibach. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit: Studies with L-carnosine and glycyl-L-proline. J. Biol. Chem. 258:14189-14192 (1983).
S. Silbernagl. Amino acids and oligopeptides. In D.W. Seldin and G. Giebisch (eds.), The Kidney: Physiology and Pathophysiology, Second Edition, Raven Press, Ltd., New York, 1992 pp. 2889-2920.
A. Bourne, K. Barnes, B. A. Taylor, A. J. Turner, and A. J. Kenny. Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid. Biochem. J. 259:69-80 (1989).
C. E. Johanson, Z. Parandoosh, and Q. R. Smith. C1-HCO3 exchange in choroid plexus: Analysis by the DMO method for cell pH. Am. J. Physiol. 249:F478-484 (1985).
V. A. Murphy, and C. E. Johanson. Na+-H+ exchange in choroid plexus and CSF in acute metabolic acidosis or alkalosis. Am. J. Physiol. 258:F1528-1537 (1990).
H. Wang, Y. J. Fei, V. Ganapathy, and F. H. Leibach. Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain. Am. J. Physiol. 275:C967-975 (1998).
H. Daniel, E. L. Morse, and S. A. Adibi. Determinants of substrate affinity for the oligopeptide/H+ symporter in the renal brush border membrane. J. Biol. Chem. 267:9565-9573 (1992).
J. T. Huang. Accumulation of peptide Tyr-D-Ala-Gly by choroid plexus during ventriculocisternal perfusion of rat brain. Neurochem. Res. 7:1541-1548 (1982).
M. Lucas. Determination of acid surface pH in vivo in rat proximal jejunum. Gut 24:734-739 (1983).
L. C. Floren, I. Bekersky, L. Z. Benet, Q. Mekki, D. Dressler, J. W. Lee, J. P. Roberts, and M. F. Hebert. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin. Pharmacol. Ther. 62:41-49 (1997).
C. Shu, H. Shen, R. F. Keep, and D. E. Smith. Role of PEPT2 in peptide/mimetic trafficking at the blood-CSF barrier: Studies in rat choroid plexus epithelial cells in primary culture. AAPS PharmSci. Suppl. 2(4):A1320 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Teuscher, N.S., Keep, R.F. & Smith, D.E. PEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexus. Pharm Res 18, 807–813 (2001). https://doi.org/10.1023/A:1011088413043
Issue Date:
DOI: https://doi.org/10.1023/A:1011088413043